Stocks and Investing Stocks and Investing
Wed, November 2, 2022
[ 12:00 AM ] - WOPRAI
Bernie McTernan Maintained (UBER) at Strong Buy with Increased Target to $54 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Andreas Argyrides Maintained (UBX) at Buy with Increased Target to $36 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
J. Bruce Chan Downgraded (ULH) to Hold and Held Target at $36 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ann Hynes Maintained (UHS) at Strong Buy with Increased Target to $126 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Benjamin Chaiken Maintained (VAC) at Buy with Decreased Target to $219 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Sami Badri Maintained (TYL) at Hold with Increased Target to $408 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Timothy Wojs Maintained (TT) at Hold and Held Target at $156 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Funk Downgraded (TWLO) to Sell and Decreased Target to $85 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Scott Buck Maintained (TRNS) at Strong Buy with Increased Target to $88 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Drew McReynolds Maintained (TRI) at Buy with Decreased Target to $120 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (TRI) at Hold with Decreased Target to $112 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ketan Mamtora Maintained (TREX) at Hold with Decreased Target to $58 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Eric Hagen Downgraded (TRTX) to Hold on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Nadine Sarwat Initiated (TLRY) at Hold and Held Target at $3.9 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ann Hynes Maintained (THC) at Strong Buy with Decreased Target to $60 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Marc Wiesenberger Downgraded (SMLR) to Hold and Decreased Target to $45 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matt Bryson Maintained (SMCI) at Hold with Increased Target to $6.5 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Frederick Havemeyer Initiated (SNOW) at Hold and Held Target at $173 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Adelson Maintained (SOFI) at Hold with Decreased Target to $7 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (SOFI) at Hold with Decreased Target to $7.5 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (SON) at Hold with Decreased Target to $64 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Rajvindra Gill Maintained (CRUS) at Strong Buy with Increased Target to $85 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (CHGG) at Hold with Increased Target to $24 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Josh Baer Maintained (CHGG) at Hold with Increased Target to $24 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Alexander Paris Maintained (CHGG) at Buy with Increased Target to $30 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mike Grondahl Maintained (CHGG) at Buy with Increased Target to $32 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Maxim Sytchev Maintained (CIGI) at Buy with Decreased Target to $122 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kyle Peterson Maintained (CDLX) at Strong Buy with Decreased Target to $14 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Maintained (CDLX) at Sell with Decreased Target to $10 on, Nov 2nd, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $13 on, Nov 2nd, 2022

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $13 on, Nov 2nd, 2022


Published on 2024-10-27 23:49:51 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Decreased Target from $14 to $13 on, Nov 2nd, 2022.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, all agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Justin Kim of "Oppenheimer" Downgraded from Buy to Hold on, Monday, August 8th, 2022
  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $14 on, Friday, August 5th, 2022
Contributing Sources